BioInsights - Mitigating risk in the gene therapy supply chain
Biologistics Strategy for Scale-Up

Mitigating risk in the gene therapy supply chain

Cell & Gene Therapy Insights 2019; 5(9), 1069–1073.

10.18609/cgti.2019.114

Published: 4 November 2019
Interview
Chad Presher

Chad Presher

Chad Presher is an Associate Director of Clinical Drug supply at Biogen. In this role Chad supports the clinical supply chains for Biogen’s Rare Disease Therapeutic Area. Prior to joining Biogen, Chad held commercial supply chain roles at Pfizer and Wyeth. Chad holds an MBA and a BS in Biology from the University of New Hampshire.